We are live on
!
Find out more
ATYR
aTyr Pharma
ATYR
ATYR
103 hedge funds and large institutions have $51.5M invested in aTyr Pharma in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less call options, than puts
Call options by funds: $3.95M | Put options by funds: $9.99M
85% less capital invested
Capital invested by funds: $336M → $51.5M (-$285M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
103
Holding in Top 10
–
Calls
$3.95M
Puts
$9.99M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$12.5M | |
| 3 | +$6.11M | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$4.71M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.42M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$18.7M | |
| 3 | -$9.06M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.16M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$7.15M |